By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



8 rue de la Croix Jarry

Paris    75013  France
Phone: 33-0-1-81-69-16-00 Fax: n/a




Company News
Cellectis (ALCLS) Announces The Issuance Of U.S. Patent 9,458,439 Following U.S. Patent 8,921,332 Issued In December 2014 10/5/2016 10:51:29 AM
Cellectis (ALCLS) Reports 2nd Quarter And First Half Year 2016 Financial Results 9/9/2016 10:41:37 AM
MIT Technology Review Names Cellectis (ALCLS) On Annual List Of 50 Smartest Companies For Second Consecutive Year 6/28/2016 9:13:30 AM
Cellectis (ALCLS) Named 2016 Technology Pioneer By The World Economic Forum 6/28/2016 9:11:45 AM
Cellectis (ALCLS) Announces First Patient Treated In Phase 1 Trial Of UCART19 In Pediatric Acute B Lymphoblastic Leukemia (B-ALL) 6/21/2016 11:30:54 AM
Cellectis (ALCLS) Reports Results From Shareholders’ General Meeting Held On May 17, 2016 5/20/2016 8:38:26 AM
New York Could Be Next Booming Bio Hub as Cellectis (ALCLS), Pfizer (PFE) and Eli Lilly (LLY) Set Up Shop There 5/17/2016 6:47:49 AM
Cellectis (ALCLS) Reports First Quarter 2016 Financial Results 5/12/2016 10:42:28 AM
Cellectis (ALCLS) To Present Data On Its Allogeneic CAR T-Cell Programs At The 19th American Society Of Gene & Cell Therapy Annual Meeting 5/3/2016 11:01:33 AM
Cellectis (ALCLS) Announces RetroNectin Supply And License Agreement With Takara Bio 3/22/2016 11:14:32 AM